ACR GUIDELINES Bundle (free trial)

Gout Hyperuricemia

American College of Rheumatology GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/631809

Contents of this Issue

Navigation

Page 4 of 9

Table 1. Important Conditions and Comorbidities to Consider When Evaluating Patients with Gout (C) Common comorbid medical conditions to consider: Metabolic syndrome: Diabetes mellitus type 2, hypertension, hyperlipidemia, obesity History of urolithiasis Important conditions that directly impact serum urate levels: Dietary factors (See Figure 3) Excessive alcohol intake (See Figure 3) Chronic kidney disease (CKD) Serum urate-elevating medications a : Niacin for hyperlipidemia iazide and loop diuretics for hypertension, so long as cessation of treatment would not exacerbate difficult-to-control hypertension cases Calcineurin inhibition with cyclosporine or tacrolimus so long as other satisfactory immune suppression agent is available In selected cases, potential genetic or acquired cause of uric acid overproduction (e.g., inborn error of purine metabolism or psoriasis, myeloproliferative, or lymphoproliferative disease, respectively) Lead intoxication a Examples of serum urate-elevating drugs that might be non-essential in a given patient and potentially replaced by alternative agents that do not elevate serum urate.

Articles in this issue

Archives of this issue

view archives of ACR GUIDELINES Bundle (free trial) - Gout Hyperuricemia